OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 90

Cryo-EM structures and binding of mouse and human ACE2 to SARS-CoV-2 variants of concern indicate that mutations enabling immune escape could expand host range
Dongchun Ni, Priscilla Turelli, Bertrand Beckert, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1011206-e1011206
Open Access | Times Cited: 19

mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review
Alberto Boretti
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
Luyi Chen, Ying He, Hongye Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling
Yongkui Li, Moran Li, Heng Xiao, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012886-e1012886
Open Access

Multiplexed discrimination of SARS-CoV-2 variants via plasmonic-enhanced fluorescence in a portable and automated device
Ying Liu, Yang Yang, Guanghui Wang, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 12, pp. 1636-1648
Closed Access | Times Cited: 18

pH-Sensitive and Biodegradable Mn3(PO4)2·3H2O Nanoparticles as an Adjuvant of Protein-Based Bivalent COVID-19 Vaccine to Induce Potent and Broad-Spectrum Immunity
Shihao Zhou, Ru-Yan Zhang, Zi-Wei You, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 7, pp. 8914-8926
Closed Access | Times Cited: 16

Electrical Detection Assay Based on Programmable Nucleic Acid Probe for Efficient Single-Nucleotide Polymorphism Identification
Yun Zhang, Bo Chen, Duo Chen, et al.
ACS Sensors (2023) Vol. 8, Iss. 5, pp. 2096-2104
Closed Access | Times Cited: 14

A Multiplexed SERS Microassay for Accurate Detection of SARS-CoV-2 and Variants of Concern
Courtney Vedelago, Junrong Li, Kym Lowry, et al.
ACS Sensors (2023) Vol. 8, Iss. 4, pp. 1648-1657
Open Access | Times Cited: 13

Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 507-507
Open Access | Times Cited: 11

Seeing the T cell Immunity of SARS-CoV-2 and SARS-CoV: Believing the Epitope-Oriented Vaccines
Can Yue, Pengyan Wang, Jinmin Tian, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 13, pp. 4052-4060
Open Access | Times Cited: 11

Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID‐19
Haoran Zhang, Qingyu Zhang, Kun Liu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 3

Synthetic Immunology—Building Immunity from the Bottom‐Up with Synthetic Cells
Oskar Staufer
Advanced NanoBiomed Research (2024)
Open Access | Times Cited: 3

Development of potent pan‐coronavirus fusion inhibitors with a new design strategy
Yuanmei Zhu, Zhongcai Gao, Xiaoli Feng, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 3

Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy
Michele Equestre, Cinzia Marcantonio, Nadia Marascio, et al.
Microorganisms (2023) Vol. 11, Iss. 11, pp. 2711-2711
Open Access | Times Cited: 10

Publication trends of research on COVID-19 and host immune response: A bibliometric analysis
Yun Xia, Ren-qi Yao, Peng-yue Zhao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 15

Green Tea Consumption and the COVID-19 Omicron Pandemic Era: Pharmacology and Epidemiology
Maksim V. Storozhuk, Siyun Lee, Jin I. Lee, et al.
Life (2023) Vol. 13, Iss. 3, pp. 852-852
Open Access | Times Cited: 8

Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp
Bangdi Zhou, D. Chen, Tingyan Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116180-116180
Open Access | Times Cited: 2

Humoral Immune Response to the SARS-CoV-2 Spike Protein Receptor Binding Motif Linear Epitopes
M. Monteiro, Guilherme C. Lechuga, Paloma Napoleão-Pêgo, et al.
(2024)
Open Access | Times Cited: 2

The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study
Xiaoju Ma, Zheng Wang, You‐Peng Chen, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2
Simone Di Micco, Rahila Rahimova, Marina Sala, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114857-114857
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top